Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 13 | 2021 | 209 | 5.570 |
Why?
|
| Coronary Artery Disease | 11 | 2021 | 313 | 4.380 |
Why?
|
| Cardiac Catheterization | 8 | 2018 | 283 | 2.190 |
Why?
|
| Drug-Eluting Stents | 6 | 2017 | 62 | 2.030 |
Why?
|
| Atherectomy, Coronary | 3 | 2019 | 12 | 1.430 |
Why?
|
| Peripheral Arterial Disease | 3 | 2021 | 173 | 1.380 |
Why?
|
| Treatment Outcome | 18 | 2022 | 5680 | 1.320 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2021 | 90 | 1.180 |
Why?
|
| Stents | 5 | 2021 | 502 | 1.150 |
Why?
|
| Femoral Artery | 2 | 2022 | 110 | 1.060 |
Why?
|
| Venous Thrombosis | 2 | 2018 | 115 | 1.020 |
Why?
|
| Coronary Angiography | 3 | 2018 | 203 | 1.000 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2021 | 168 | 0.990 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 916 | 0.990 |
Why?
|
| Radiation Dosage | 3 | 2018 | 132 | 0.950 |
Why?
|
| Shock, Cardiogenic | 2 | 2020 | 102 | 0.930 |
Why?
|
| Ultrasonography, Interventional | 4 | 2017 | 107 | 0.930 |
Why?
|
| Radial Artery | 2 | 2016 | 53 | 0.840 |
Why?
|
| Coronary Vessels | 2 | 2015 | 119 | 0.830 |
Why?
|
| Occupational Exposure | 2 | 2018 | 315 | 0.790 |
Why?
|
| Vascular Closure Devices | 1 | 2022 | 3 | 0.790 |
Why?
|
| Lower Extremity | 3 | 2021 | 166 | 0.750 |
Why?
|
| Aortic Valve | 2 | 2013 | 190 | 0.720 |
Why?
|
| Angioplasty, Balloon | 1 | 2021 | 58 | 0.710 |
Why?
|
| Endovascular Procedures | 3 | 2017 | 655 | 0.710 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2013 | 176 | 0.690 |
Why?
|
| Humans | 34 | 2022 | 63449 | 0.650 |
Why?
|
| Acute Coronary Syndrome | 2 | 2014 | 253 | 0.630 |
Why?
|
| Foreign-Body Migration | 2 | 2017 | 23 | 0.630 |
Why?
|
| Vascular Calcification | 1 | 2019 | 26 | 0.620 |
Why?
|
| Device Removal | 2 | 2017 | 68 | 0.610 |
Why?
|
| Iliac Vein | 1 | 2018 | 9 | 0.570 |
Why?
|
| Vascular Access Devices | 1 | 2017 | 15 | 0.530 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 67 | 0.510 |
Why?
|
| Sirolimus | 2 | 2015 | 93 | 0.510 |
Why?
|
| Radiography, Interventional | 3 | 2013 | 75 | 0.510 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 126 | 0.490 |
Why?
|
| Popliteal Artery | 2 | 2017 | 27 | 0.490 |
Why?
|
| Absorbable Implants | 1 | 2015 | 9 | 0.490 |
Why?
|
| Everolimus | 1 | 2015 | 22 | 0.490 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 169 | 0.480 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 772 | 0.480 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 190 | 0.480 |
Why?
|
| Ulnar Artery | 1 | 2015 | 11 | 0.470 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 76 | 0.470 |
Why?
|
| Heart | 1 | 2017 | 283 | 0.460 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2015 | 19 | 0.460 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 173 | 0.450 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 51 | 0.440 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 33 | 0.430 |
Why?
|
| Protective Clothing | 1 | 2013 | 29 | 0.410 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 39 | 0.400 |
Why?
|
| Radiation Protection | 1 | 2013 | 26 | 0.400 |
Why?
|
| Lead | 1 | 2013 | 43 | 0.400 |
Why?
|
| Calcinosis | 1 | 2013 | 85 | 0.390 |
Why?
|
| Paclitaxel | 1 | 2013 | 99 | 0.390 |
Why?
|
| Radiation Injuries | 1 | 2013 | 67 | 0.390 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 95 | 0.380 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 104 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 1644 | 0.370 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 540 | 0.370 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2019 | 226 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 724 | 0.360 |
Why?
|
| Occupational Diseases | 1 | 2013 | 267 | 0.350 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 189 | 0.330 |
Why?
|
| Neoplasms | 2 | 2017 | 1364 | 0.330 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 144 | 0.310 |
Why?
|
| Time Factors | 4 | 2017 | 3768 | 0.310 |
Why?
|
| Risk Factors | 4 | 2018 | 5354 | 0.270 |
Why?
|
| Male | 12 | 2017 | 29893 | 0.260 |
Why?
|
| Female | 10 | 2017 | 32883 | 0.240 |
Why?
|
| Anticoagulants | 2 | 2019 | 495 | 0.220 |
Why?
|
| Hemostatic Techniques | 1 | 2022 | 11 | 0.200 |
Why?
|
| Echocardiography | 2 | 2017 | 501 | 0.190 |
Why?
|
| Vascular Patency | 1 | 2021 | 139 | 0.180 |
Why?
|
| Catheters | 1 | 2021 | 75 | 0.180 |
Why?
|
| Risk Assessment | 2 | 2018 | 2079 | 0.170 |
Why?
|
| Arteries | 1 | 2021 | 81 | 0.170 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2020 | 24 | 0.160 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Standard of Care | 1 | 2019 | 27 | 0.150 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 24 | 0.150 |
Why?
|
| Prosthesis Design | 2 | 2017 | 229 | 0.150 |
Why?
|
| Warfarin | 1 | 2019 | 111 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1094 | 0.140 |
Why?
|
| Limb Salvage | 1 | 2017 | 70 | 0.130 |
Why?
|
| Tomography, Optical Coherence | 1 | 2019 | 223 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 298 | 0.130 |
Why?
|
| Attitude | 1 | 2017 | 99 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2017 | 124 | 0.130 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2017 | 111 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 165 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 126 | 0.120 |
Why?
|
| Equipment Design | 1 | 2017 | 352 | 0.120 |
Why?
|
| Ischemia | 1 | 2017 | 205 | 0.120 |
Why?
|
| Cardiology | 1 | 2017 | 168 | 0.120 |
Why?
|
| Patient Selection | 1 | 2017 | 490 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2016 | 102 | 0.110 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 84 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 465 | 0.110 |
Why?
|
| Critical Illness | 1 | 2017 | 321 | 0.110 |
Why?
|
| Comorbidity | 1 | 2017 | 1120 | 0.110 |
Why?
|
| Hemorrhage | 1 | 2016 | 267 | 0.110 |
Why?
|
| Heart Aneurysm | 1 | 2013 | 23 | 0.100 |
Why?
|
| Aneurysm, False | 1 | 2013 | 52 | 0.100 |
Why?
|
| Vena Cava Filters | 1 | 2012 | 23 | 0.090 |
Why?
|
| Vascular System Injuries | 1 | 2012 | 21 | 0.090 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 33 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 77 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 84 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2013 | 261 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5463 | 0.070 |
Why?
|
| Middle Aged | 2 | 2017 | 17615 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2013 | 65 | 0.030 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2013 | 44 | 0.020 |
Why?
|
| Phlebography | 1 | 2012 | 44 | 0.020 |
Why?
|
| Aortography | 1 | 2012 | 62 | 0.020 |
Why?
|
| Aged | 1 | 2013 | 14449 | 0.010 |
Why?
|